Profile data is unavailable for this security.
Mergers & acquisitions
| Acquired company | ATAI:NMQ since announced | Transaction value |
|---|---|---|
| Beckley Psytech Ltd | 64.50% | -- |
Data delayed at least 15 minutes, as of Feb 17 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trevi Therapeutics Inc | 0.00 | -45.86m | 1.30bn | 26.00 | -- | 6.86 | -- | -- | -0.3713 | -0.3713 | 0.00 | 1.48 | 0.00 | -- | -- | 0.00 | -34.19 | -45.07 | -36.67 | -51.11 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -64.84 | -- | 31.21 | -- |
| Azenta Inc | 594.95m | 28.69m | 1.32bn | 3.00k | 45.81 | 0.7686 | 15.44 | 2.22 | 0.6252 | -1.26 | 12.98 | 37.26 | 0.2891 | 4.03 | 4.00 | 198,317.70 | 1.39 | -0.3901 | 1.57 | -0.4328 | 44.59 | 45.32 | 4.82 | -1.73 | 2.61 | -- | 0.00 | -- | 3.55 | 8.85 | 200.38 | -- | -3.24 | -- |
| Monte Rosa Therapeutics Inc | 181.54m | 20.95m | 1.34bn | 147.00 | 73.28 | 4.61 | 45.73 | 7.37 | 0.2506 | 0.2506 | 2.20 | 3.98 | 0.4685 | -- | 65.30 | 1,354,761.00 | 5.41 | -33.14 | 6.24 | -39.19 | -- | -- | 11.54 | -563.84 | -- | -- | 0.00 | -- | -- | -- | 46.29 | -- | 23.56 | -- |
| Septerna Inc | 22.05m | -58.81m | 1.36bn | 75.00 | -- | 3.48 | -- | 61.54 | -1.51 | -1.51 | 0.5304 | 8.71 | 0.0565 | -- | 4.98 | 293,933.30 | -15.06 | -- | -16.99 | -- | -- | -- | -266.77 | -- | -- | -- | 0.00 | -- | 611.92 | -- | -12,762.79 | -- | -- | -- |
| AtaiBeckley Inc | 3.02m | -154.19m | 1.38bn | 54.00 | -- | 5.72 | -- | 456.54 | -0.8136 | -0.8136 | 0.0161 | 0.6644 | 0.0138 | -- | 0.3354 | 55,981.48 | -70.56 | -45.69 | -77.07 | -50.03 | -- | -- | -5,104.20 | -2,658.81 | -- | -- | 0.00 | -- | -1.91 | -- | -271.09 | -- | 37.97 | -- |
| Kodiak Sciences Inc | 0.00 | -217.34m | 1.38bn | 123.00 | -- | 50.69 | -- | -- | -4.12 | -4.12 | 0.00 | 0.447 | 0.00 | -- | -- | 0.00 | -73.58 | -33.79 | -82.91 | -35.95 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.36 | -- | -1.75 | -- |
| Rapport Therapeutics Inc | 0.00 | -97.70m | 1.39bn | 69.00 | -- | 2.71 | -- | -- | -2.71 | -2.71 | 0.00 | 10.74 | 0.00 | -- | -- | 0.00 | -22.55 | -- | -23.12 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -125.11 | -- | -- | -- |
| Novavax Inc | 1.06bn | 341.75m | 1.41bn | 952.00 | 4.81 | -- | 3.73 | 1.32 | 1.80 | 1.80 | 6.29 | -0.9643 | 0.7362 | 7.87 | 16.49 | 1,118,331.00 | 23.63 | -39.12 | 53.33 | -248.97 | 91.82 | -- | 32.10 | -67.41 | 2.24 | 17.15 | 2.66 | -- | -30.65 | 105.39 | 65.60 | -- | 47.71 | -- |
| Intellia Therapeutics Inc | 57.53m | -445.81m | 1.42bn | 403.00 | -- | 1.89 | -- | 24.60 | -4.27 | -4.27 | 0.5488 | 6.46 | 0.0548 | -- | 5.78 | 142,749.40 | -42.49 | -33.78 | -46.95 | -37.16 | -- | -- | -774.94 | -790.71 | -- | -- | 0.00 | -- | 59.55 | 6.07 | -7.86 | -- | -3.19 | -- |
| Zenas Biopharma Inc | 15.00m | -189.90m | 1.44bn | 130.00 | -- | 5.75 | -- | 95.80 | -12.67 | -12.67 | 0.4565 | 4.65 | 0.0414 | -- | -- | 115,384.60 | -52.35 | -- | -60.38 | -- | -- | -- | -1,265.99 | -- | -- | -116.56 | 0.2709 | -- | -90.00 | -- | -322.87 | -- | -- | -- |
| Alvotech SA | 573.35m | 69.50m | 1.45bn | 1.01k | 22.17 | -- | 13.76 | 2.52 | 0.2093 | 0.2093 | 1.93 | -0.5671 | 0.434 | 1.53 | 4.30 | 567,111.80 | 5.26 | -- | 6.38 | -- | 55.59 | -- | 12.12 | -201.24 | 0.7376 | 2.57 | 1.16 | -- | 426.84 | 42.86 | 57.98 | -- | 47.91 | -- |
| Corvus Pharmaceuticals Inc | 0.00 | -15.08m | 1.47bn | 31.00 | -- | 18.20 | -- | -- | -0.2004 | -0.2004 | 0.00 | 0.961 | 0.00 | -- | -- | 0.00 | -21.65 | -46.71 | -35.55 | -55.72 | -- | -- | -- | -- | -- | -38.28 | 0.00 | -- | -- | -- | -130.47 | -- | -- | -- |
| AnaptysBio Inc | 169.47m | -84.63m | 1.49bn | 136.00 | -- | -- | -- | 8.77 | -2.82 | -2.82 | 5.70 | -1.07 | 0.4004 | -- | 3.86 | 1,246,081.00 | -19.99 | -19.96 | -22.14 | -21.08 | -- | -- | -49.94 | -200.59 | -- | -- | 1.10 | -- | 432.03 | 62.73 | 11.24 | -- | -14.96 | -- |
Data as of Feb 17 2026. Currency figures normalised to AtaiBeckley Inc's reporting currency: US Dollar USD
7.76%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Adage Capital Management LPas of 30 Sep 2025 | 5.43m | 1.50% |
| Deep Track Capital LPas of 31 Dec 2025 | 4.68m | 1.29% |
| ARK Investment Management LLCas of 31 Dec 2025 | 3.31m | 0.91% |
| Morgan Stanley Investment Management, Inc.as of 31 Dec 2025 | 2.87m | 0.79% |
| Marshall Wace LLPas of 31 Dec 2025 | 2.68m | 0.74% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 2.27m | 0.62% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2025 | 1.94m | 0.53% |
| Morgan Stanley & Co. LLCas of 31 Dec 2025 | 1.85m | 0.51% |
| Eagle Health Investments LPas of 31 Dec 2025 | 1.68m | 0.46% |
| HRT Financial LPas of 31 Dec 2025 | 1.47m | 0.41% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
